Metaplastic Carcinoma of the Axillary Breast With Heterologous Mesenchymal (Chondroid) Differentiation: A Difficult Case and Literature Review [0.03%]
异质性肉瘤样分化腋乳癌一例及文献复习
Chun-Ming Chang,Ho Yin Pekkle Lam
Chun-Ming Chang
Metaplastic breast carcinoma is an invasive carcinoma with a high differentiation rate of the neoplastic epithelium toward mesenchymal-like epithelium. It comprises of only less than 1% of all breast cancers. Although 80% to 90% of metaplas...
Coping in Post-Mastectomy Breast Cancer Survivors and Need for Intervention: Systematic Review [0.03%]
乳腺癌术后幸存者应对策略及干预需求：系统综述
Anju Mishra,Jayajith Nair,Anjali Midha Sharan
Anju Mishra
Background: Breast cancer is the most prominent cancer type to affect women. Surgical treatment of invasive breast cancers involves mastectomy. Due to mastectomy, women are subjected to social, emotional, and cultural pro...
Implementation of Risk-Stratified Breast Cancer Prevention With a Polygenic Risk Score Test in Clinical Practice [0.03%]
在临床实践中使用多基因风险评分检测实施分层乳腺癌预防措施
Peeter Padrik,Mikk Puustusmaa,Neeme Tõnisson et al.
Peeter Padrik et al.
Background: Breast cancer (BC) screening with mammography reduces mortality but considers currently only age as a risk factor. Personalized risk-based screening has been proposed as a more efficient alternative. For that,...
Real-World Survival and Treatment Regimens Across First- to Third-Line Treatment for Advanced Triple-Negative Breast Cancer [0.03%]
晚期三阴性乳腺癌一线至三线治疗的生存和治疗模式的真实世界研究
Alan Celik,Tobias Berg,Maj-Britt Jensen et al.
Alan Celik et al.
Background: Metastatic triple-negative breast cancer (mTNBC) is an aggressive subtype of breast cancer with poor survival. Currently, the literature lacks comprehensive real-world evidence on locally recurrent and mTNBC p...
Homologous Recombination Abnormalities Associated With BRCA1/2 Mutations as Predicted by Machine Learning of Targeted Next-Generation Sequencing Data [0.03%]
机器学习预测BRCA1/2突变相关的同源重组修复通路异常
Maher Albitar,Hong Zhang,Andrew Pecora et al.
Maher Albitar et al.
Background: Homologous recombination deficiency (HRD) is the hallmark of breast cancer gene 1/2 (BRCA1/2)-mutated tumors and the unique biomarker for predicting response to double-strand break (DSB)-inducing drugs. The de...
Hormone Receptor-Positive / HER2-Negative Early Breast Cancer High-Risk Population: An Algorithm for Optimization Systemic Adjuvant Treatment Based on 2022 Updates [0.03%]
激素受体阳性/HER2阴性早期乳腺癌高危人群：基于2022年更新的系统性辅助治疗优化路径算法
Daniel González-Hurtado,Sergio Rivero,Juan Carlos Samamé Pérez-Vargas et al.
Daniel González-Hurtado et al.
Prognostic and predictive factors for early and late distant distance recurrence risk in estrogen-receptor positive and HER2-receptor negative early breast cancer are well known, but not all these variables work equally for the prediction. ...
Iopromide for Contrast-Enhanced Mammography: A Systemic Review and Meta-Analysis of Pertinent Literature [0.03%]
碘普胺用于对比增强型乳腺X线摄影：相关文献的系统评价和荟萃分析
Jan Endrikat,Hassan Khater,Alexander Dp Boreham et al.
Jan Endrikat et al.
Background: Contrast-enhanced mammography (CEM) is an emerging breast imaging modality. Clinical data is scarce. Objectives: To summari...
Clinical Treatment Score Post-5 Years as a Tool for Risk Estimation of Late Recurrence in Thai Patients With Estrogen-Receptor-Positive, Early Breast Cancer: A Validation Study [0.03%]
临床治疗评分在五年之后作为评估泰国患者雌激素受体阳性早期乳腺癌晚期复发风险的工具：一项验证性研究
Thitiya Dejthevaporn,Panchanin Patanayindee
Thitiya Dejthevaporn
Background: The risk of late distant recurrence (LDR) of estrogen receptor (ER)-positive breast cancer continues even after 5 years of endocrine treatment. Clinical Treatment Score after 5 years (CTS5) was developed and v...
Evaluation of the Potential Diagnostic Role of the Lnc-MIAT, miR-29a-3p, and FOXO3a ceRNA Networks as Noninvasive Circulatory Bioindicator in Ductal Carcinoma Breast Cancer [0.03%]
评估Lnc-MIAT，miR-29a-3p和FOXO3a ceRNA网络在乳腺导管癌中作为非侵入性循环生物标志物的潜在诊断作用
Shokufeh Razi,Hossein Mozdarani,Roudabeh Behzadi Andouhjerdi
Shokufeh Razi
Background: Over the last few decades, tremendous progress has been achieved in the early detection and treatment of breast cancer (BC). However, the prognosis remains unsatisfactory, and the underlying processes of carci...
Marking Techniques for Targeted Axillary Dissection Among Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy [0.03%]
新辅助化疗后的阳性淋巴结乳腺癌患者进行腋窝区精准解剖的标记技巧
Inês Gante,João Pedro Maldonado,Margarida Figueiredo Dias
Inês Gante
Invasive breast cancer with axillary lymph node (LN) invasion is a continuing problem worldwide. The morbidity associated with axillary LN dissection along with the high rate of nodal downstaging after neoadjuvant chemotherapy (NACT) made t...